Voyager Therapeutics Inc.

05/12/2021 | Press release | Distributed by Public on 05/12/2021 05:36

Voyager Therapeutics Presents New Preclinical Data Showing Reduction of Pathological Tau with Vectorized Anti-Tau Antibody